Gene Query: BTD

Dataset Description Geneva Score
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 35.73
Role for citron kinase in prostate cancer growth 17.21
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 15.35
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 11.97
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 10.64
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 10.5
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 10.5
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 9.96
Expression by CD133+ cells isolated from the adult human exocrine pancreas 9.65
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 9.62
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 9.56
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 8.87
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 8.53
Genome-wide functional assessment of enhancer activities in the human genome 8.49
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 8.1
Expression charcaterization of an internal protocol developed to differentiate RPE cells 7.32
Evaluating pre-clinical models for studying NASH driven HCC. 7.3
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 6.83
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 6.77
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 6.73
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 6.44
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 5.94
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 5.84
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 5.8
Paxillin regulates genomic networks in prostate cancer [C4-2] 5.46
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 5.38
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 5.18
Identification of a LIF-responsive replication-competent human β cell 4.95
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 4.94
An RNA-centric dissection of host complexes controlling flavivirus infection 4.9
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 4.9
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 4.8
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 4.75
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 4.74
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 4.74
Comparing gene expression in iPSC derived RPE from control and AMD donors 4.65
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 4.58
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 4.35
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 4.31
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 4.11
Gene expression signatures of innate lymphoid cells from human blood 4.1
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 3.94
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 3.94
Paxillin regulates genomic networks in prostate cancer [LNCaP] 3.89
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 3.87
Development of an In Vitro Human Liver System for Interrogating Non-Alcoholic Steatohepatitis 3.75
Differential expression analysis of RNA-seq data from melanocytes driven by tumor cell-derived exosomes 3.72
Chromatin landscape of human visceral and subcutaneous adipocytes 3.71
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 3.66
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 3.5
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 3.5
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 3.44
Novel Atherogenic Pathways from the Differential Transcriptiome Analysis of Diabetic Epicardial Adipose Tissue 3.41
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 3.4
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 3.4
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 3.29
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 3.26
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 3.26
Gene expression analysis of human liver progenitor-like cells in culture 3.24
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 3.22
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 3.2
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 3.19
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 3.12
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 3.12
Identification of transcription start sites for human A549 cell line using ReCappable-seq 3.08
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 3.07
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 3.05
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 3.05
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 3.02
Transcriptome of human white and brown adipose tissue biopsies 3.02
EWSR1 influences alternative splicing through direct and indirect mechanisms 2.96
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 2.96
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 2.94
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 2.94
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 2.94
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 2.94
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 2.91
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 2.89
Zone dependent distinctive gene expression profile of the normal human liver tissue 2.79
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 2.78
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 2.77
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 2.76
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 2.73
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA_seq_Whole] 2.72
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 2.72
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 2.72
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 2.71
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 2.71
RNA-seq analyses of human prostate cancer cells 2.63
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 2.59
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 2.57
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 2.54
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 2.54
Patient-derived luminal breast cancer xenografts with progestins 2.54
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 2.52
RNA-seq of tumor cells following angiopellosis extravasation 2.52
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 2.52
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 2.51
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 2.47
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 2.47
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 2.46
Gene expression analysis of dengue-infected cells 2.44
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 2.44
Transcriptome-wide analysis of adipose circular RNAs reveals their dynamic regulation in obesity and functional role in adipogenesis 2.4
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 2.39
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 2.37
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 2.36
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 2.35
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 2.34
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver 2.34
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver [RNA-Seq] 2.34
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 2.33
CHD1 regulates cell fate determination by activation of differentiation-induced genes 2.32
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 2.31
Paxillin regulates genomic networks in prostate cancer [PC3] 2.3
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 2.28
The role of FAM46C in myeloma cells 2.26
The role of FAM46C in myeloma cells [sequencing] 2.26
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 2.21
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 2.2
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 2.2
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 2.2
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 2.19
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 2.19
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 2.19
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 2.12
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 2.11
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 2.11
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 2.11
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 2.09
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 2.08
Transcriptomic analysis of LSD1 2.08
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 2.07
EWS-Fli and LNC regulated genes in comparison to GFP samples 2.06
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 2.05
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 2.04
Regulation of Lipids is Central to Replicative Senescence 2.04
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 2.01
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 2.01
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 2.01
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 2.01
Identification of IL-27 as potent regulator of inflammatory osteolysis associated with vitamin E-blended ultra-high molecular weight polyethylene debris of orthopedic implants 2.0
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 2.0
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 1.99
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 1.99
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 1.98
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 1.96
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 1.94
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 1.92
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 1.92
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 1.91
UBC9 knockdown in bladder cancer T24 cell lines 1.9
Transcriptome analysis of BAP1 knockout and restoration 1.88
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 1.88
Transcriptomic analysis of ERR alpha orphan nuclear receptor 1.86
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 1.86
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 1.86
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 1.84
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 1.84
RNA Seq of Alagille liver biopsies 1.83
Alagille_Nodder 1.83
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 1.83
RNA sequencing to compare gene expession in control and PF228-treated hepatic stellate cells 1.82
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 1.82
An optimization system for isolating and sequencing of single human colon cancer cells 1.82
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 1.81
Random mono-allelic expression in MECP2-mutated cells 1.79
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 1.78
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 1.72
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 1.72
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 1.72
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 1.72
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 1.7
Joint-specific DNA transcriptome signatures in rheumatoid arthritis [RNA-seq] 1.7
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 1.68
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 1.68
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 1.67
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 1.67
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 1.65
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 1.65
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 1.62
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 1.62
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 1.62
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 1.62
GATA3-mediated chromatin reprogramming in breast cancer cells 1.61
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 1.6
Interaction between mitoNEET and NAF-1 in cancer cells 1.59
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 1.56
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 1.55
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 1.55
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 1.55
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 1.55
Single-cell analysis of adult human ovary using 10X genomics 1.55
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 1.54
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 1.54
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 1.54
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 1.54
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 1.54
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 1.54
An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells 1.53
Accurate annotation of human protein-coding small open reading frames 1.53
RNA-seq of MDA-MB-231 cells with TET1 knockout 1.53
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 1.52
Effect of FGF13 depletion on the H460 cell line 1.52
MiR-26 dampens IL-6 production by down-regulating TNF-a/NF-kB signaling through silencing HMGA1 and MALT1 and not by directly targeting IL-6 mRNA 1.52
Real-time observation of light-controlled transcription in living cells 1.5
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 1.49
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 1.49
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 1.49
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 1.49
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 1.47
RNAseq analysis of ESRP regulated splicing events in prostate cancer 1.46
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 1.45
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 1.45
Gene expression changes in human melanoma cell lines compared to primary melanocytes 1.45
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 1.44
T47D RNA-seq and ChrRNA-seq data 1.44
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 1.43
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 1.42
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 1.41
LNCaP treated with iBET 1.4
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [ribosome profiling] 1.39
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 1.39
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 1.38
RNA-sequencing of human liver tissue 1.38
Energy Metabolism during Anchorage-Independence 1.38
Lysine benzoylation is a novel histone mark 1.38
Lysine benzoylation is a novel histone mark [RNA-seq] 1.38
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 1.37
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 1.37
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 1.35
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 1.33
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 1.33
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 1.32
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 1.32
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 1.32
Ebola virus (EBOV) infection of ARPE-19 cells 1.32
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence [RNA-seq] 1.32
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence 1.32
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 1.31
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 1.3
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 1.29
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 1.29
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 1.28
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 1.28
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 1.26
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 1.26
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 1.26
Androgen Receptor-regulated genes in prostate cancer cells 1.25
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 1.25
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 1.25
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 1.24
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 1.24
Transcriptome analyses of human pancreatic islets and pseudoislets 1.23
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 1.23
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 1.23
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 1.23
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 1.23
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 1.23
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 1.22
Transcriptome profiling of omental adipose tissues in human obesity by RNA-Seq 1.2
Mutational landscape of splicing genes and functional consequences across 33 cancer types 1.2
The cytokine environment influence on human skin-derived T cells 1.19
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 1.18
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 1.17
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 1.17
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 1.17
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 1.14
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 1.13
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 1.13
STX4 Over-Expression in Human islets 1.13
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 1.12
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 1.12
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 1.11
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 1.11
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 1.1
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 1.1
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 1.1
Analysis of human, chimpanzee, macaque and mouse tissue transcriptomes using Next Generation Sequencing 1.1
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 1.1
High-throughput sequencing of PROMPT-enriched samples. 1.09
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 1.06
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 1.06
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 1.06
RNA-seq of IL-4 stimulated human keratinocytes 1.05
Genome-wide identification of cancer-specific alternative splicing in circRNA 1.05
The DNA methylation landscape of human melanoma [RNA-Seq] 1.04
The DNA methylation landscape of human melanoma 1.04
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 1.04
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 1.04
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 1.03
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 1.03
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 1.02
Divergent expression and metabolic functions of human glucuronosyltransferases through alternative splicing 1.02
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 1.02
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 1.01
Molecular analysis of renal cell carcinoma with unclassfied histology 1.01
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 1.01
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 1.0
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 1.0
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 1.0
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 1.0
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 1.0
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 0.99
HNRNPM-regulated splicing dependencies in prostate cancer 0.99
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 0.99
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 0.99
Gene expression profile difference among renal location in a stone former 0.98
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 0.97
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 0.96
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 0.95
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 0.94
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 0.94
The impact of pro-inflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes 0.93
Gene expression profiling of papillary thyroid cancer from central and invasive regions 0.93
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 0.92
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 0.92
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 0.92
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 0.91
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 0.91
RNA editing in nascent RNA affects pre-mRNA splicing 0.91
A genomic study of the contribution of DNA methylation to regulatory evolution in primates 0.91
Discovering human diabetes-risk gene function with genetics and physiological assays 0.89
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 0.86
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 0.82
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 0.82
De novo reconstruction of human adipose reveals conserved lncRNAs as regulators of brown adipogenesis 0.81
Transcriptional profiling of microglia; current state of the art and future perspectives 0.8
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 0.8
Large-scale profiling of intracellular signalling pathway activation reveals major distinctions between airway smooth muscle cells of asthmatics and non-asthmatics. 0.79
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 0.79
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 0.79
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 0.79
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 0.79
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 0.78
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 0.77
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 0.77
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 0.76
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 0.76
RNA sequencing of matched nephrectomy samples [RNA-seq] 0.76
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 0.75
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 0.75
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 0.74
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription 0.74
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription.[RNA-seq and ChIP-seq] 0.74
Characterization of human ILC2 subsets 0.74
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 0.72
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 0.72
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 0.71
Efficient derivation of microglia-like cells from human pluripotent stem cells 0.71
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 0.71
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 0.71
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 0.7
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 0.7
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 0.7
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 0.68
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 0.68
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 0.68
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 0.68
Epigenomic conservation of transposable element silencing [RNA-seq] 0.68
Epigenomic conservation of transposable element silencing 0.68
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 0.67
Copper Regulation of HIF-1 Transcription Activity 0.66
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 0.66
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 0.66
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 0.66
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 0.66
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 0.65
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 0.65
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 0.65
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 0.65
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 0.64
Effect of drugs on transcriptomic profiles 0.63
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 0.63
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 0.63
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 0.62
RNA-seq analyisis of PUM2 knockout cells 0.62
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 0.61
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 0.6
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 0.58
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 0.58
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 0.57
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 0.56
Differential gene expression of human melanoma cells [RNA-seq] 0.56
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 0.56
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 0.56
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 0.54
DRB/GRO-Seq -/+ UV 0.53
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 0.51
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 0.5
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 0.5
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 0.49
Genome-wide mapping of TEL-AML1 targets in acute leukemia 0.48
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 0.48
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 0.47
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 0.47
Effect of Hotair overexpression in human breast cancer cell lines 0.47
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 0.46
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 0.46
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 0.45
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 0.44
ELP1 splicing correction reverses proprioceptive sensory loss in familial dysautonomia 0.43
MRTF activates TEAD-YAP target gene expression 0.43
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 0.42
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 0.4
IRF1 regulates IFN dependent and independent gene expression 0.4
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 0.4
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 0.39
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 0.39
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 0.38
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 0.38
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 0.38
Hepatocyte maturation 0.35
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  0.35
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 0.35
Expression profiling of MCF-7 cells with treatment of TCDD 0.34
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 0.34
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 0.34
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 0.34
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 0.33
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 0.32
A549 cell transcriptome responses to infection with H7N9 influenza virus 0.31
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 0.31
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 0.31
Gene expression of collecting duct carcinoma of the kidney 0.3
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 0.29
4sUDRB-seq: measuring transcription elongation and initiation genomewide 0.29
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 0.28
Next Generation Sequencing Study of Circadian Changes in Transcriptome of Human Pineal Gland 0.28
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 0.28
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 0.28
Epigenetic reprogramming of melanoma cells by vitamin C treatment 0.28
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 0.26
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 0.25
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 0.25
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 0.25
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 0.25
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 0.25
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 0.24
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 0.24
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 0.24
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 0.24
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 0.24
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 0.24
The Cushing's disease adipose gene expression profile reveals effects of long term glucocorticoids on adipose tissue lipid, protein and glucose metabolism 0.24
Preclinical model of obesity and ER-positive breast cancer 0.24
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 0.23
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.23
RNA-Seq and expression data from human adipose tissue 0.23
Generation and persistence of human tissue-resident memory T cells in lung transplantation 0.23
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 0.22
Gene expression analysis of human hepatocellular cancers 0.22
Gene Expression Signature in Adipose Tissue of Acromegaly Patients 0.21
Measure transcript integrity using RNA-seq data 0.2
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.2
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 0.19
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 0.19
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 0.19
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.19
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.19
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 0.17
Impaired DNA damage metabolism promotes autoimmunity in TREX1 deficiency  0.17
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 0.16
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.16
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 0.16
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 0.16
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 0.15
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 0.15
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity 0.14
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 0.14
Enhancer activation during EGF response 0.13
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 0.12
Comprehensive comparative analysis of 5’ end RNA sequencing methods 0.12
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 0.12
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 0.12
The transcriptome and chromatin accessbility landscape of mammalian germline 0.11
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.11
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 0.1
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 0.1
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 0.1
Interphase condensins regulate ligand-depedent enhancer activation 0.1
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 0.1
Regulation of hypoxia-inducible factor activity by ZMYND8 0.08
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.08
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 0.08
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 0.06
RNA-Sequencing of HepG2 cells treated with TGFBeta 0.05
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 0.05
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 0.05
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 0.04
quanTIseq: quantifying immune contexture of human tumors 0.04
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.02
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 0.02
Illumina HiSeq Sequencing on Breast cancer PDX samples 0.02
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism. 0.01
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism: Liver RNA profiles of lean non-diabetic, obese non-diabetic as well as obese diabetic humans. 0.01
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation 0.01
miRNAs affected by antagomiR-17 treatment 0.0
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.0
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation